Skip to content

Efficacy study of oral astaxanthin to improve brain function for the middle aged and elderly

Efficacy study of oral astaxanthin to improve brain function for the middle aged and elderly - Efficacy study of oral astaxanthin to improve brain function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022299
Enrollment
60
Registered
2016-05-15
Start date
2016-05-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

The treatment group will receive oral administration of two jellies including 2 mg astaxanthin twice daily (8 mg astaxanthin/ 4 jellies /day) for 8 consecutive weeks. The placebo group will receive o

Sponsors

JX Nippon Oil & energy Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age at the time of giving informed consent: 45 to 64 years

Exclusion criteria

Exclusion criteria: (1) Subjects who are difficult to discriminate color (2) Subjects with bad eyesight, or are diagnosed with amblyopia or blindness (3) Subjects with bad hearing, or are diagnosed with hearing loss or permanent hearing loss (4) Subjects who get a score of 20 or less on the Revised HDS-R (5) Subjects who smoke, or quit smoking within one year before pre-inspection (6) Subjects with history of cranial nerve disease (7) Subjects with depressive symptoms or history of them (8) Subjects who are under hormone treatment or are diagnosed with menopause (9) Subjects who have some irregular schedules during the study, due to night work or something (10) Subjects who drink much alcohol (11) Subjects who have done brain function test before (12) Subjects who are under treatment of brain function, sleep or stress, or are prescribed with medicine for them (13) Subjects who continuously take medicine, health foods, Food for Specified Health Uses or Foods with Function Claims including substance related to brain function, antioxidant, sleep or stress (14) Subjects who was given or donated 200 ml or 400 ml whole blood within three months before pre-inspection (15) Subjects who participated in other study within one month before pre-inspection, or are going to participate in other study during the study (16) Subjects who have a disease which needs regular medication, or have a history of the disease (17) Subjects who are judged as unsuitable for the study by investigator because of clinical test, anthropometric test and physical examination in pre-inspection (18) Subjects who are in danger of allergy to the ingredients of the test food (19) Subjects who are pregnant or lactating, or plan to become pregnant or lactate during the study (20) Subjects who are judged as unsuitable for the study because of lifestyle questionnaire (21) Subjects who are judged as unsuitable for the study by investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Memory test of words, Recall test of words and Stroop test

Secondary

MeasureTime frame
POMS VAS for fatigue Action of the bowels Serum concentration of astaxanthin

Countries

Japan

Contacts

Public ContactMasahiro Hayashi

JX Nippon Oil & energy Corporation Biotechnology Business Group Biotechnology Business Unit Specialty Chemicals & Materials Company

hayashi.masahiro@jxgr.com03-6257-4559

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026